Zobrazeno 1 - 10
of 47
pro vyhledávání: '"van den Dobbelsteen Gp"'
Publikováno v:
Expert Review of Vaccines. 11:1121-1137
Pertussis has recently re-emerged in well-vaccinated populations most likely due to a combination of pathogen adaptation and waning of vaccine-induced pertussis immunity. Changes in genomic content of the etiologic agent, Bordetella pertussis, observ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::572b7ab234b7c7a241ce3430b529f3e2
https://doi.org/10.1586/erv.12.83
https://doi.org/10.1586/erv.12.83
Autor:
Spijkerman J, van Gils EJ, Veenhoven RH, Hak E, Yzerman EP, van der Ende A, Wijmenga-Monsuur AJ, van den Dobbelsteen GP, Sanders EA, Spijkerman, Judith, van Gils, Elske J M, Veenhoven, Reinier H, Hak, Eelko, Yzerman, Ed P F, van der Ende, Arie, Wijmenga-Monsuur, Alienke J, van den Dobbelsteen, Germie P J M, Sanders, Elisabeth A M
Publikováno v:
Emerging Infectious Diseases; Apr2011, Vol. 17 Issue 4, p584-591, 8p
Autor:
Rodenburg GD, van Gils EJ, Veenhoven RH, Bogaert D, van den Dobbelsteen GP, Berbers GA, Sanders EA
Publikováno v:
Journal of Pediatrics; Dec2011, Vol. 159 Issue 6, p965-970.e1, 1p
Autor:
Dowling DJ; Department of Medicine, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Sanders H; Janssen Vaccines and Prevention B.V. , Leiden , Netherlands., Cheng WK; Department of Medicine, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Precision Vaccine Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA., Joshi S; Department of Medicine, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA; Precision Vaccine Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA., Brightman S; Department of Medicine, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA; Precision Vaccine Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA., Bergelson I; Department of Medicine, Division of Infectious Diseases, Boston Children's Hospital , Boston, MA , USA., Pietrasanta C; Department of Medicine, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Precision Vaccine Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA; Neonatal Intensive Care Unit, Department of Clinical Sciences and Community Health, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy., van Haren SD; Department of Medicine, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Precision Vaccine Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA., van Amsterdam S; Janssen Vaccines and Prevention B.V. , Leiden , Netherlands., Fernandez J; Janssen Research and Development, LLC , Spring House, PA , USA., van den Dobbelsteen GP; Janssen Vaccines and Prevention B.V. , Leiden , Netherlands., Levy O; Department of Medicine, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Precision Vaccine Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA.
Publikováno v:
Frontiers in immunology [Front Immunol] 2016 Dec 08; Vol. 7, pp. 562. Date of Electronic Publication: 2016 Dec 08 (Print Publication: 2016).
Autor:
Geurtsen J; Crucell Holland B.V, one of the Janssen Pharmaceutical Companies of Johnson & Johnson - Bacterial Vaccines Research and Development, PO Box 2048, Archimedesweg 4-6, 2333 CN Leiden, The Netherlands., Fae KC, van den Dobbelsteen GP
Publikováno v:
Expert review of vaccines [Expert Rev Vaccines] 2014 Oct; Vol. 13 (10), pp. 1229-40. Date of Electronic Publication: 2014 Aug 01.
Autor:
Queenan AM; Janssen Pharmaceutical Research and Development - Bacterial Vaccines Research and Development, 600 Welsh and McKean Rd, Spring House, Pennsylvania, USA., Fernandez J, Shang W, Wiertsema S, van den Dobbelsteen GP, Poolman J
Publikováno v:
Expert review of vaccines [Expert Rev Vaccines] 2014 Oct; Vol. 13 (10), pp. 1265-70. Date of Electronic Publication: 2014 Jul 17.
Autor:
van Westen E; Centre for Immunology of Infectious Diseases and Vaccines, Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands., Rodenburg GD, van Gils EJ, Tcherniaeva I, Berbers GA, Cowell L, Goldblatt D, Rots NY, van den Dobbelsteen GP, Sanders EA
Publikováno v:
Vaccine [Vaccine] 2013 Dec 02; Vol. 31 (49), pp. 5834-42. Date of Electronic Publication: 2013 Oct 10.
Autor:
Poolman JT; Bacterial Vaccine Discovery & Early Development, Crucell, PO Box 2048, Archimedesweg 4-6, 2333 CN Leiden, The Netherlands., Peeters CC, van den Dobbelsteen GP
Publikováno v:
Expert review of vaccines [Expert Rev Vaccines] 2013 Dec; Vol. 12 (12), pp. 1379-94.
Autor:
Kaaijk P; Unit Vaccinology, Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands. Patricia.Kaaijk@rivm.nl, van der Ark AA, van Amerongen G, van den Dobbelsteen GP
Publikováno v:
Journal of applied toxicology : JAT [J Appl Toxicol] 2013 Jun; Vol. 33 (6), pp. 521-6. Date of Electronic Publication: 2012 Mar 08.
Autor:
van de Waterbeemd B; National Institute for Public Health and the Environment (RIVM), Vaccinology, Bilthoven, The Netherlands. bas.van.de.waterbeemd@intravacc.nl, Zomer G, Kaaijk P, Ruiterkamp N, Wijffels RH, van den Dobbelsteen GP, van der Pol LA
Publikováno v:
PloS one [PLoS One] 2013 May 31; Vol. 8 (5), pp. e65157. Date of Electronic Publication: 2013 May 31 (Print Publication: 2013).